ImportRefusal LogoImportRefusal

Gufic Biosciences Limited

⚠️ High Risk

FEI: 3003200255 • Navsari, Gujarat • INDIA

FEI

FEI Number

3003200255

📍

Location

Navsari, Gujarat

🇮🇳

Country

INDIA
🏢

Address

National Highway No. 8, Near Grid, Navsari, Gujarat, India

High Risk

FDA Import Risk Assessment

57.4
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

9
Total Refusals
4
Unique Violations
1/7/2026
Latest Refusal
5/18/2005
Earliest Refusal

Score Breakdown

Violation Severity
69.2×40%
Refusal Volume
37.0×30%
Recency
91.0×20%
Frequency
4.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
1/7/2026
58JCP04CHORIONIC GONADOTROPIN
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/17/2024
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/10/2022
54YFK99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/28/2013
60QIS40LIDOCAINE HCL (ANESTHETIC)
118NOT LISTED
Detroit District Office (DET-DO)
12/16/2011
60QAS40LIDOCAINE HCL (ANESTHETIC)
27DRUG GMPS
Southwest Import District Office (SWI-DO)
8/15/2007
61WIY18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
16DIRECTIONS
New York District Office (NYK-DO)
8/15/2007
60QIY07LIDOCAINE
16DIRECTIONS
New York District Office (NYK-DO)
6/12/2006
61WBR18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
5/18/2005
61WAY18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)

Frequently Asked Questions

What is Gufic Biosciences Limited's FDA import refusal history?

Gufic Biosciences Limited (FEI: 3003200255) has 9 FDA import refusal record(s) in our database, spanning from 5/18/2005 to 1/7/2026.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Gufic Biosciences Limited's FEI number is 3003200255.

What types of violations has Gufic Biosciences Limited received?

Gufic Biosciences Limited has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Gufic Biosciences Limited come from?

All FDA import refusal data for Gufic Biosciences Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.